Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen

Among those with HIV, anemia is a strong risk factor for disease progression and death independent of CD4 count and viral load. Understanding the role of anemia in HIV treatment is critical to developing strategies to reduce morbidity and mortality. We conducted a prospective analysis among 10,259...

Full description

Saved in:
Bibliographic Details
Main Authors: Simbarashe Takuva, Mhairi Maskew, Alana T. Brennan, Ian Sanne, A. Patrick MacPhail, Mathew P. Fox
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Tropical Medicine
Online Access:http://dx.doi.org/10.1155/2013/162950
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548343220273152
author Simbarashe Takuva
Mhairi Maskew
Alana T. Brennan
Ian Sanne
A. Patrick MacPhail
Mathew P. Fox
author_facet Simbarashe Takuva
Mhairi Maskew
Alana T. Brennan
Ian Sanne
A. Patrick MacPhail
Mathew P. Fox
author_sort Simbarashe Takuva
collection DOAJ
description Among those with HIV, anemia is a strong risk factor for disease progression and death independent of CD4 count and viral load. Understanding the role of anemia in HIV treatment is critical to developing strategies to reduce morbidity and mortality. We conducted a prospective analysis among 10,259 HIV-infected adults initiating first-line ART between April 2004 and August 2009 in Johannesburg, South Africa. The prevalence of anemia at ART initiation was 25.8%. Mean hemoglobin increased independent of baseline CD4. Females, lower BMI, WHO stage III/IV, lower CD4 count, and zidovudine use were associated with increased risk of developing anemia during follow-up. After initiation of ART, hemoglobin improved, regardless of regimen type and the degree of immunosuppression. Between 0 and 6 months on ART, the magnitude of hemoglobin increase was linearly related to CD4 count. However, between 6 and 24 months on ART, hemoglobin levels showed a sustained overall increase, the magnitude of which was similar regardless of baseline CD4 level. This increase in hemoglobin was seen even among patients on zidovudine containing regimens. Since low hemoglobin is an established adverse prognostic marker, prompt identification of anemia may result in improved morbidity and mortality of patients initiating ART.
format Article
id doaj-art-a6bee28ff4274d80bbed49acbdbfaaf4
institution Kabale University
issn 1687-9686
1687-9694
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Tropical Medicine
spelling doaj-art-a6bee28ff4274d80bbed49acbdbfaaf42025-02-03T06:14:16ZengWileyJournal of Tropical Medicine1687-96861687-96942013-01-01201310.1155/2013/162950162950Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART RegimenSimbarashe Takuva0Mhairi Maskew1Alana T. Brennan2Ian Sanne3A. Patrick MacPhail4Mathew P. Fox5Clinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2041, South AfricaHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South AfricaCenter for Global Health and Development, Boston University, Boston, MA 02118, USAClinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2041, South AfricaClinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2041, South AfricaHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South AfricaAmong those with HIV, anemia is a strong risk factor for disease progression and death independent of CD4 count and viral load. Understanding the role of anemia in HIV treatment is critical to developing strategies to reduce morbidity and mortality. We conducted a prospective analysis among 10,259 HIV-infected adults initiating first-line ART between April 2004 and August 2009 in Johannesburg, South Africa. The prevalence of anemia at ART initiation was 25.8%. Mean hemoglobin increased independent of baseline CD4. Females, lower BMI, WHO stage III/IV, lower CD4 count, and zidovudine use were associated with increased risk of developing anemia during follow-up. After initiation of ART, hemoglobin improved, regardless of regimen type and the degree of immunosuppression. Between 0 and 6 months on ART, the magnitude of hemoglobin increase was linearly related to CD4 count. However, between 6 and 24 months on ART, hemoglobin levels showed a sustained overall increase, the magnitude of which was similar regardless of baseline CD4 level. This increase in hemoglobin was seen even among patients on zidovudine containing regimens. Since low hemoglobin is an established adverse prognostic marker, prompt identification of anemia may result in improved morbidity and mortality of patients initiating ART.http://dx.doi.org/10.1155/2013/162950
spellingShingle Simbarashe Takuva
Mhairi Maskew
Alana T. Brennan
Ian Sanne
A. Patrick MacPhail
Mathew P. Fox
Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
Journal of Tropical Medicine
title Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
title_full Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
title_fullStr Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
title_full_unstemmed Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
title_short Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
title_sort anemia among hiv infected patients initiating antiretroviral therapy in south africa improvement in hemoglobin regardless of degree of immunosuppression and the initiating art regimen
url http://dx.doi.org/10.1155/2013/162950
work_keys_str_mv AT simbarashetakuva anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen
AT mhairimaskew anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen
AT alanatbrennan anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen
AT iansanne anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen
AT apatrickmacphail anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen
AT mathewpfox anemiaamonghivinfectedpatientsinitiatingantiretroviraltherapyinsouthafricaimprovementinhemoglobinregardlessofdegreeofimmunosuppressionandtheinitiatingartregimen